Apollo Hospitals Enterprise Limited vs Eris Lifesciences Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Eris Lifesciences Limited (ERIS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Apollo Hospitals Enterprise Limited vs Eris Lifesciences Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability22
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ERIS takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
25.19
13.46
P/B ratio
4.81
0.22%
Dividend yield
0.53%
₹135.04
EPS
₹45.33

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
15.87%
17.31%
Return on capital
13.28%
14.94%
EBITDA margin
35.79%
7.94%
Net margin
20.69%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
22.92%
33.35%
Profit CAGR (3Y)
20.08%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹15,832 Cr
₹25,229 Cr
Revenue
₹3,129 Cr
₹2,003 Cr
Net profit
₹648 Cr
0.90
Debt / equity
0.60
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Eris Lifesciences Limited
  • + ["Company has delivered good sales growth of 20.9% CAGR over last 5 years"]
  • − []
Apollo Hospitals Enterprise Limited full analysis Eris Lifesciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.